ProtoKinetix, Incorporated ("ProtoKinetix" or the "Company") is a research and development stage biotechnology company focused on scientific medical research of AFGPs (Anti-Freeze Glycoproteins) or anti-aging glycoproteins, and has developed and patented a family of hyper-stable, potent glycopeptides trademarked as AAGPs that enhance the therapeutic results and can reduce the cost of stem cell medicine. Due to the anti-inflammatory effect of AAGPTM molecules, the Company is currently in the process of directing major efforts to target the direct treatment of diseases that have a major inflammatory component.